Dont miss SGLT Tools - PowerPoint slide library for SGLT2 inhibitors

Patient Scenario: Desired PTH, hyperphosphatemia and low or normal calcium

doc_thinking

 

Assessing the Clinical and Laboratory Parameters

Phosphate control is suboptimal in this patient. 

The PTH level is at the target range in this patient.  This may be as a result of current use of vitamin D sterols in an effort to control hyperparathyroidism.  However, it may be that the vitamin D sterol is adversely influencing phosphate balance by increasing absorption.


Approximately 4% of all patients are in this category.


Therapeutic Options:


Return to bone and mineral resource home

 

 

 



ukidneyisup